KRAS and lung adenocarcinoma: In this Lung-iKRAS (L-iKRAS) model, first described by the Varmus laboratory (8), expression of oncogenic KRAS in club cells, in combination with loss-of-function mutations in tumor suppressor genes, efficiently drives formation of lung adenocarcinoma in both male and female mice.